MP Medicus Pharma Ltd. Stock: price and management transactions · United States · SEC (Form 4)Follow the Medicus Pharma Ltd. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €16.5m. The latest transaction was filed on 9 September 2026 (46 - Compensation for services). Among the most active insiders: Mehmud, Faisal. Every trade is free.
€512,883
1 ops.
Sell Volume
Analyst consensus: bullish or bearish? Analysts rate Medicus Pharma Ltd. Strong Buy (bullish), based on 4 analysts. Average price target: US$4.48.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 September 2026
All Executives32 Thresholds0 Prospectus0 Other0
Declarations 32 total
● 5 - Senior Officer of Issuer · Executives · 4 Sept 2026
588,235 shares @ CA$0.1705 Common Shares TSXSEDI:4775808 ● 5 - Senior Officer of Issuer · Executives · 4 Sept 2026
735,294 shares @ CA$0.1705 Common Shares TSXSEDI:4775807 ● 5 - Senior Officer of Issuer · Executives · 4 Sept 2026
1,470,588 shares @ CA$0.1705 Common Shares TSXSEDI:4775806 ● 5 - Senior Officer of Issuer · Executives · 18 Nov 2024
Common Shares TSXSEDI:4775805 ● 5 - Senior Officer of Issuer · Executives · 4 Sept 2026
1,470,588 shares @ CA$0.1705 Common Shares TSXSEDI:4775804 ● 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 4 Sept 2026
2,941,176 shares @ CA$0.1705 Common Shares TSXSEDI:4775803 ● 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 29 Sept 2023
Common Shares TSXSEDI:4775403 ◇ 5 - Senior Officer of Issuer · Executives · 3 Sept 2026
100,000 shares Options TSXSEDI:4775148 ◇ 5 - Senior Officer of Issuer · Executives · 3 Sept 2026
125,000 shares Options TSXSEDI:4775147 ◇ 5 - Senior Officer of Issuer · Executives · 3 Sept 2026
250,000 shares Options TSXSEDI:4775146 ◇ 5 - Senior Officer of Issuer · Executives · 3 Sept 2026
250,000 shares Options TSXSEDI:4775145 ◇ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 3 Sept 2026
500,000 shares Options TSXSEDI:4775144 ◆ Chief Executive Officer · Executives · 4 Sept 2026
2,941,176 shares @ US$0.1705 3.03% mcap 100.0% of flow Common Shares, no par value SEC:0000950142-26-002518:0
◆ President and CFO · Executives · 4 Sept 2026
1,470,588 shares @ US$0.1705 1.52% mcap 100.0% of flow Common Shares, no par value SEC:0000950142-26-002519:0
◆ Chief Scientific Officer · Executives · 4 Sept 2026
588,235 shares @ US$0.1705 0.61% mcap 100.0% of flow Common Shares, no par value SEC:0000950142-26-002520:0
◆ Chief Medical Officer · Executives · 4 Sept 2026
1,470,588 shares @ US$0.1705 1.52% mcap 100.0% of flow Common Shares, no par value SEC:0000950142-26-002521:0
◆ Chief Operating Officer · Executives · 4 Sept 2026
735,294 shares @ US$0.1705 0.76% mcap 100.0% of flow Common Shares, no par value SEC:0000950142-26-002522:0
◇ 5 - Senior Officer of Issuer · Executives · 3 Jun 2026
250,000 shares Options TSXSEDI:4731875 ◇ 5 - Senior Officer of Issuer · Executives · 3 Jun 2026
200,000 shares Options TSXSEDI:4731873 ◇ 4 - Director of Issuer · Executives · 3 Jun 2026
50,000 shares Options TSXSEDI:4731870 ◇ 4 - Director of Issuer · Executives · 3 Jun 2026
50,000 shares Options TSXSEDI:4731865 ◇ 4 - Director of Issuer · Executives · 3 Jun 2026
50,000 shares Options TSXSEDI:4731864 ◇ 4 - Director of Issuer · Executives · 3 Jun 2026
50,000 shares Options TSXSEDI:4731861 ◇ 3 - 10% Security Holder of Issuer · Executives · 3 Jun 2026
50,000 shares Options TSXSEDI:4731860 ◇ 4 - Director of Issuer · Executives · 3 Jun 2026
50,000 shares Options TSXSEDI:4731858 25 of 32 declarations
Load more (7 remaining) 关于 Medicus Pharma Ltd. Medicus Pharma Ltd. 是一家专注于开发创新疗法的制药公司。该公司在纳斯达克上市。